关键词：蛋白质；体细胞；负责各功能方面；治疗性蛋白质；治疗；疾病
摘 要：Proteins are macromolecules comprising a combination of amino acids. They are a primary constituent of body cells and are responsible for the various functional aspects of these cells. Therapeutic proteins are used to effectively treat a wide array of diseases such as protein deficiency diseases; chronic diseases such as cancer, rheumatoid arthritis, ankylosing spondylitis, diabetes; infections such as HIV, hepatitis A, hepatitis B, and hepatitis C; and other medical conditions such as genetic disorders, anemia cases related to kidney dialysis, and cancer related anemia. Therapeutic proteins mostly consist of recombinant forms of naturally occurring proteins. The first therapeutic protein recombinant DNA-derived insulin was launched in the market in 1980. Since then, the use of protein therapeutics has witnessed rapid growth in the pharmaceuticals market. Moreover, it is anticipated that the treatment methodology for chronic diseases is expected to shift from conventional drugs to protein therapeutics in the near future. Protein therapeutics include monoclonal antibodies, insulin, erythropoietin, interferon, G-CSF, human growth hormone, blood clotting factors, and follicle stimulating hormones.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by product type

PART 07: Global monoclonal antibody drugs market

Introduction

Market overview

Market drivers

Market challenges

Market trends

Vendors of global monoclonal antibody drugs market

PART 08: Global insulin market

Introduction

Market overview

Market drivers

Market challenges

Market trends

Insulin market in Europe

Vendors of global insulin market

PART 09: Global erythropoietin market

Introduction

Market overview

Market drivers

Market challenges

Market trends

Erythropoietin market in Japan

Vendors of global erythropoietin market

PART 10: Global human growth hormone market

Introduction

Market overview

Market drivers

Market challenges

Market trends

Vendors of global human growth hormone market

PART 11: Market segmentation by therapy area

Metabolic and endocrine disorders

Hematopoiesis

Fertility

Cancer

Autoimmune diseases

Infectious diseases

Protein vaccine

PART 12: Market segmentation by protein function

Enzymatic and regulatory activity

Special targeting activity

Vaccines

Protein diagnostics

PART 13: Geographical segmentation

Global protein therapeutics market by geographical

segmentation 2015-2020

Protein therapeutics market in Americas

Protein therapeutics market in EMEA

Protein therapeutics market in APAC

PART 14: Market drivers

Increased demand for monoclonal antibodies

Availability of favorable reimbursement policies

Increasing prevalence of chronic diseases

Promising drug pipeline

Frequent innovations

PART 15: Impact of drivers

PART 16: Market challenges

Patent expiration of top-selling drugs

Stringent regulations

High cost of therapy

Fierce market competition

Risk of side effects

PART 17: Impact of drivers and challenges

PART 18: Market trends

Patient assistance programs

Strategic alliances

Emergence of targeted therapies

Shifting focus toward untapped markets

Increase in public awareness

PART 19: Vendor landscape

Competitive scenario

Market share analysis 2015

Other prominent vendors

PART 20: Key vendor analysis

AbbVie

Amgen

F.Hoffmann-La Roche

Johnson & Johnson

Merck Serono

Novo Nordisk

PART 21: Appendix

List of abbreviations

PART 22: Explore Technavio